Disease: Hyperaldosteronism- familial type 1
- <em>CACNA1D</em> Gene Polymorphisms Associate With Increased Blood Pressure and Salt Sensitivity of Blood Pressure in White Individuals
- A novel mutation of KCNJ1 identified in an affected child with nephrolithiasis
- AUP1 Regulates the Endoplasmic Reticulum-Associated Degradation and Polyubiquitination of NKCC2
- Bartter Syndrome-Related Variants Distribution: Brazilian Data and Its Comparison with Worldwide Cohorts
- Classic and current concepts in adrenal steroidogenesis: a reappraisal
- Clinical Findings and Genetic Analysis of Nine Mexican Families with Bartter Syndrome
- Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor: An In Situ Aldosterone Imaging Study
- Functional characterization of SLC12A1 gene variants in 3 patients with Bartter syndrome type Ⅰ
- Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3
- Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions
- Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review
- Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis in Lung Adenocarcinoma Cells
- Multiple Endocrine Neoplasia Type 1
- Neonatal Bartter syndrome diagnosed by rapid genomics following low risk pre-conception carrier screening
- Novel SLC12A1 mutations cause Bartter syndrome in two patients with different prognoses
- Paradoxes in magnesium transport in type 1 Bartter's syndrome and Gitelman's syndrome: a modeling analysis
- Pathophysiology of bilateral hyperaldosteronism
- Primary Hyperaldosteronism
- Primary Hyperaldosteronism
- Protein Quality Control of NKCC2 in Bartter Syndrome and Blood Pressure Regulation
- Recurrent transient severe hypocalcaemia in two siblings with type 1 Bartter syndrome
- Report on three cases of familial primary aldosteronism type IV
- Severe Bartter syndrome type 1: Prompt postnatal management thanks to antenatal identification of SLC12A1 pathogenic variants
- Sex-specific Association of Primary Aldosteronism With Visceral Adiposity
- Systematic Review of Therapeutic Agents and Long-Term Outcomes of Familial Hyperaldosteronism Type 1
- Testosterone inhibits human wild-type and chimeric aldosterone synthase activity in vitro
- Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 Gene <em>CACNA1D</em> Associated with Familial Sinus Node Dysfunction and Focal Idiopathic Epilepsy
- Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 Gene CACNA1D Associated with Familial Sinus Node Dysfunction and Focal Idiopathic Epilepsy